Table 1.
Parameters | Sham
|
HT
|
P value for two-way ANOVA
|
||||
---|---|---|---|---|---|---|---|
Lean | Obese | Lean | Obese | Diet | HT | DietXHT | |
Body weight (kg) | 31.4±4.3 | 45.0±5.7* | 35.7±2.1 | 45.3±1.1*† | 0.001 | 0.30 | 0.52 |
MAP (mmHg) | 108.0±7.1 | 113.9±5.8 | 122.67±4.4* | 137.2±5.5*†‡ | 0.09 | 0.004 | 0.004 |
Heart rate (bpm) | 61.3±2.6 | 67.0±7.0 | 76.6±5.4* | 84.5±6.4*‡ | 0.54 | 0.018 | 0.87 |
RPP (mmHgxbpm) | 83.4±7.5 | 91.9±10.6 | 115.7±8.3* | 137.7±9.7*† | 0.24 | 0.002 | 0.017 |
Total cholesterol (mg/dl) | 97.0±2.9 | 388.0±48.1* | 85.4±5.0 | 346.7±40.6*† | <0.001 | 0.81 | 0.58 |
LDL (mg/dl) | 38.3±2.9 | 243.0±21.9* | 32.4±3.0 | 187.3±27.3*† | <0.001 | 0.66 | 0.09 |
Triglycerides (mg/dl) | 26.0±5.6 | 37.6±13.9 | 17.4±2.9 | 34.6±5.6 | 0.16 | 0.77 | 0.10 |
HOMA-IR (μU/ml×mg/dl) | 3.6±0.3 | 6.7±2.4* | 2.6±0.5 | 10.5±2.9*† | 0.005 | 0.63 | 0.006 |
TNF-α (pg/ml) | 38.1±15.4 | 55.0±11.8 | 138.9±49.7* | 101.4±23.4* | 0.77 | 0.029 | 0.52 |
sE-selectin (pg/ml) | 5.6±3.9 | 5.7±5.7 | 15.4±7.1 | 36.8±10.8*†‡ | 0.17 | 0.017 | 0.005 |
8-epi-Isoprostane (pg/ml) | 126.9±24.4 | 142.2±27.4 | 97.9±8.0 | 139.5±12.8 | 0.27 | 0.49 | 0.73 |
PRA (ng/ml/hr) | 0.02±0.01 | 0.10±0.03 | 0.07±0.02 | 0.16±0.06* | 0.005 | 0.07 | 0.94 |
LVMM (g) | 39.8±2.6 | 44.7±3.7 | 49.0±4.7 | 52.1±4.3* | 0.25 | 0.034 | 0.10 |
E/A | 1.6±0.1 | 1.5±0.2 | 1.5±0.2 | 1.1±0.2*‡ | 0.28 | 0.021 | 0.023 |
Stroke volume (ml) | 36.5±3.6 | 35.6±4.6 | 34.0±2.5 | 35.8±2.2 | 0.74 | 0.74 | 0.67 |
Ejection fraction (%) | 59.5±4.2 | 62.0±3.3 | 63.8±2.0 | 62.4±3.7 | 0.96 | 0.54 | 0.60 |
Cardiac output (mlxbpm) | 2.5±0.2 | 2.4±0.2 | 2.5±0.3 | 2.9±0.2‡ | 0.40 | 0.15 | 0.023 |
MAP: mean arterial pressure; RPP: rate pressure product; LDL: low-density lipoprotein; HOMA-IR: homeostasis model assessment insulin resistance; TNF-α: tumor necrosis factor-α; PRA: plasma renin activity; LVMM: left ventricular muscle mass.
p<0.05 vs. Lean-sham,
p<0.05 vs. Lean-HT,
p<0.05 vs. Obese-sham.